Established in 2013 and rooted in innovation, Pulnovo Medical is a FDA breakthrough designated device company, a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure. With the world’s first and potentially best-in-class approved device products in pulmonary hypertension (PADN system), Pulnovo Medical is committed to leveraging our deep expertise in the science of PADN with the goal to market our innovative therapeutic solutions and benefit patients around the world.
Pulnovo plans to expand its therapy to southeast asia and south america and advance clinical development in europe and north america in 2024~2026.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesACC.24 Learning Pathways? (select all that apply)
Heart Failure and Cardiomyopathies, Pulmonary Vascular DiseaseFirst time Exhibitor?
Yes